NPR

At $2.1 Million, New Gene Therapy Is The Most Expensive Drug Ever

The Food and Drug Administration approved a new gene therapy for a rare but devastating genetic disorder. The drugmaker says the cost is worth it because it's a one-time treatment that saves lives.
Zolgensma, a new drug approved by the FDA Friday, costs more than $2 million. Source: Novartis

The federal Food and Drug Administration has approved a gene therapy for a rare childhood disorder that is now the most expensive drug on the market. It costs $2.125 million per patient.

But for those patients lucky enough to get it, it appears it can save their lives with a one-time treatment.

Three-year-old Donovan Weisgarber is one of those patients. When he was born he seemed perfectly healthy. But within weeks, it became clear something was terribly wrong.

"It was about when he was about one month old that when

You're reading a preview, sign up to read more.

More from NPR

NPR7 min read
How Georgia Became A Surprising Bright Spot In The U.S. Solar Industry
Solar is booming in Georgia, and it's not because of state mandates supporting renewable energy or concerns about climate change. Instead, powerful market forces are driving the growth.
NPR2 min readPolitics
Supreme Court Strikes Down Ban On Trademarking 'Immoral,' 'Scandalous' Words, Symbols
The decision paves the way for a clothing line, FUCT, to get its trademark. But the justices were split on how far is too far and which words they would find to be the most vulgar and profane.
NPR6 min readPolitics
U.S. Mideast Plan Rejected By Palestinian Leaders, Panned By Former U.S. Envoys
The White House unveiled its economic peace proposal for Palestinians on Saturday: $50 billion for Palestinians and countries in the region. It isn't clear who would contribute the funding.